Atlas Trials

Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT

Clinical trial NCT05532826 · UNKNOWN

Trial details

NCT number
NCT05532826
Sponsor
Beijing Friendship Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Active Epstein-Barr Virus InfectionVirus-Associated Hemophagocytic Syndrome
Start date
2022-10-08
Primary completion
2023-09-15
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.